Fed. Circ. Affirms Hanmi Win In Generic Nexium Patent Suit
The Federal Circuit on Thursday found that Hanmi Pharmaceutical Co. Ltd.'s generic version of AstraZeneca AB's acid reflux drug Nexium does not infringe two of AstraZeneca's patents, upholding a lower court's...To view the full article, register now.
Already a subscriber? Click here to view full article